VAPAWAY.EU - Research and education on VAP prevention
  • Home
  • Articles
  • GuideLines
  • Links
  • About VAPAWAY
  • Training
  • Contacts

Login








Lost Password?

Register to receive updated data on VAPAWAY initiative

Agenda

 

9 - 12 March 2010

ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)

ISICEM

 

9 -11 June 2010

EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)

EACTA

 

12-15 June 2010

ESA European Society of Anaesthesiology - Helsinki (Finland)

ESA

 

18-22 September 2010

ERS European Respiratory Society - Barcellona (Spain)

ERS

 

9 -13 October 2010

ESICM European Society of Intensive Care Medicine - Barcellona (Spain)

ESICM

  

 

> International events   

> Local events 

WELCOME TO THE VAPAWAY WEBSITE

The VAPAWAY website is aimed at developing and coordinating actions and sharing knowledge among healthcare professionals dedicated to the care and treatment of patients in the intensive care.

Our focus is to:

- develop a European evidence-based guideline for VAP prevention as a response to the growing need for European harmonisation on this topic.

- facilitate the exchange of information & develop tools such as e-learning programs and educational surveys, to give healthcare professionals the means to become key players in VAP prevention.

Login or register now.

LATEST NEWS

INADEQUATE STATISTICAL POWER OF PUBLISHED COMPARATIVE COHORT STUDIES ON VAP TO DETECT MORTALITY DIFF

Falagas ME et al 

About this article:"This is a systematic review on comparative cohort studies on VAP to detect mortality differences. Authors identified 39 eligible articles. The median difference in mortality between cohorts was 10%. Authors claimed about the relatively small number of patients included in the different studies wich makes difficult to detect important differences in mortality."

Read more...
 
COMPARISON OF SEMI-QUANTITATIVE ENDOTRACHEAL ASPIRATES TO QUANTITATIVE NON-BRONCHOSCOPIC BRONCHOALVE PDF Print E-mail
Friday, 29 January 2010
Fujitani S, Cohen-Melamed MH, Tuttle RP, Delgado E, Taira Y, Darby JM. 
Department of Critical Care, University of Pittsburgh, Pittsburgh, PA, USA.
Respir Care. 2009 Nov;54(11):1453-61.
Comment in: Respir Care. 2009 Nov;54(11):1446-8.

BACKGROUND: Current strategies for diagnosing ventilator-associated pneumonia (VAP) favor the use of quantitative methods; however, semi-quantitative cultures of endotracheal aspirates are still commonly used.

METHODS: The microbiological results of patients with suspected VAP who had both quantitative cultures with non-bronchoscopic bronchoalveolar lavage (BAL) and semi-quantitative cultures of endotracheal aspirate obtained within 24 hours of each other were retrospectively reviewed and compared, using a quantitative threshold of >or=10(4) colony-forming units/mL as a reference standard. RESULTS: 256 patients with paired cultures were identified. Concordance between endotracheal aspirate (any growth of pathogens) and non-bronchoscopic BAL was complete in 58.2% and completely discordant in 23.8%. The sensitivity and specificity of endotracheal aspirate were 65.4% and 56.1%, which improved to 81.2% and 61.9% when antibiotic management decisions were considered in the analysis. Twenty-six patients had endotracheal aspirate cultures that were falsely negative for pathogens, with 61.5% of these patients demonstrating growth of non-fermenting Gram-negative rods or methicillin-resistant Staphylococcus aureus (MRSA) on non-bronchoscopic BAL. Overall, 45 patients (17.5%) among the entire cohort had false positive endotracheal aspirate cultures, with 19 of these patients (42.2%) demonstrating growth of non-fermenting Gram-negative rods or MRSA.

CONCLUSIONS: Semi-quantitative cultures of endotracheal aspirate are poorly concordant with quantitative cultures obtained via non-bronchoscopic BAL. Although the performance of endotracheal aspirate improves when antibiotic treatment is considered, guiding therapy on the basis of semi-quantitative cultures may still result in failure to identify potentially multiple-drug-resistant pathogens, and would also tend to promote excessive antibiotic usage. Our data support the use of quantitative cultures in diagnosing VAP.

 
< Prev   Next >
Select and watch
from the following webinars

 


Join us on www.smartonweb.org

Partner

VAPAWAY is proudly supported by Covidien.

http://www.covidien.com